Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.50 -0.31 (-0.78%)
As of: Sep 30, 2026 · 10:08 AM EDT

Teva Pharmaceutical Industries (TEVA) Capital Expenditures (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) posted Capital Expenditures of $104 million for Q2 2026, up 8.3% from $96 million a year earlier but down 38.1% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Capital Expenditures (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Teva Pharmaceutical Industries was $550 million, up 10.0% year-over-year; for FY2025, it came in at $501 million, up 0.6% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of -2.8% (FY2020 to FY2025).
  • In prior years, Teva Pharmaceutical Industries' Capital Expenditures was $498 million in FY2024 (-5.3%), $526 million in FY2023 (-4.0%), $548 million in FY2022 (-2.5%) and $562 million in FY2021 (-2.8%).
  • Quarterly Capital Expenditures has run from a low of $96 million in Q2 2025 to a high of $168 million in Q1 2026 over five years.
  • On a year-over-year basis, Capital Expenditures has increased in each of the last three quarters, with growth averaging 6.5% over the last eight quarters.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2026, with growth of 32.3%; the weakest was Q2 2024, with a decline of 18.5%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $168 million (Q1 2026), $142 million (Q4 2025) and $136 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Teva Pharmaceutical Industries 45.31 Bn 32.16 Bn 2.15 Bn 104.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104.00 Mn
Mar 31, 2026 168.00 Mn
Dec 31, 2025 142.00 Mn
Sep 30, 2025 136.00 Mn
Jun 30, 2025 96.00 Mn
Mar 31, 2025 127.00 Mn
Dec 31, 2024 129.00 Mn
Sep 30, 2024 148.00 Mn
Jun 30, 2024 97.00 Mn
Mar 31, 2024 124.00 Mn
Dec 31, 2023 119.00 Mn
Sep 30, 2023 149.00 Mn
Jun 30, 2023 119.00 Mn
Mar 31, 2023 139.00 Mn
Dec 31, 2022 142.00 Mn
Sep 30, 2022 122.00 Mn
Jun 30, 2022 127.00 Mn
Mar 31, 2022 157.00 Mn
Dec 31, 2021 153.00 Mn
Sep 30, 2021 146.00 Mn
API Access

Teva Pharmaceutical Industries Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TEVA&period=max&api_key=YOUR_API_KEY